Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof

Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof

US Patent 9586961 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seiz2025
Alcohol derivatives as Kv7 potassium channel openers2025
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase 2024
Alcohol derivatives as KV7 potassium channel openers2023
Powdered composition comprising a complex between a cannabinoid and a basic ion 2022
Alcohol derivatives as KV7 potassium channel openers2022
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase 2022
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesteras2022
Bicyclic amines as novel JAK kinase inhibitors2020
5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid deri2020
Alcohol derivatives of carboxamides as Kv7 potassium channel openers2020
Positive allosteric modulators of nicotinic acetylcholine receptor2018